JULY 24, 2024 by George Mason University Development of the SIV Rev-dependent vectors to target SIV reservoirs. Credit: Gene Therapy (2024). DOI: 10.1038/s41434-024-00467-9Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in the journal Gene Therapy, that found an HIV-like...